Certainty , What We Do Know

A lot of speculation at present which leads to even more assumptions , great to see so many opinions of the forum but this thread is for the facts.

1, Pharmaust through BRI have successfully re-formulated Monepantal to be A, Palatable , B 10 times more efficacy , C Monepantal as a metabolite continues to starve cancer of its ability to replicate for several days after initial consumption.

2, Phase I clearly identified the highest absorption of any previous attempts to make MPL orally available. ( Micronisation)

3, Beagles in the USA Phase I ate the Pills freely from the ground and from clinicians hands.



4, we know that 6 of 7 dogs showed positive response to the previous unpalatable pills formulated by Juniper. Either reducing tumors or placing into stasis..

5. The Previous Phase II identified a High Quality of life by reducing the size of glands in the groin, armpits and throat of dogs diagnosed with Lymphoma.
assumption would be that a higher quality of End Of Life was achieved,, eg your K9 mate is to far gone but his or her final weeks or months on MPL would enable them to still walk and be comfortable. Caught early enough stasis of Lymphoma can be achieved (live with the Cancer)

6, the previous Human Trials,,carried out on Human patients that had failed all previous standard of care showed a reduction in the blood marker LT70 PSK , this is the fuel that spurs on cancer cell reproduction, by reducing this particular blood marker you can starve Lymphoma B cancer cells and deny them the ability to replicate.

7, The Olivia Newton John Cancer Foundation has independently tested the New Formula , "Pharmapantal" on 30 Human Cancers ,, showing a truly positive effect on 26 human cancers.


8 Elanco have an Option , Global Manufacturing and Sales and Distribution , Elanco have set up a Division DC Vets to specifically market and sell in K9 Oncology Treatments to vets , which they supply circa 73,000 vets in the USA over 10,000 in the UK ,



9, Pharmaust have patented the use of MPL for Cancer and have purchased circa 50 more patents for the use of MPL as a Treatment.

10, Pharmaust as a company are very modest (my opinion "to Modest") but have steadily increased marketing budget Q on Q , from only $5k to $25k then $45k to this Q $65k.

11, Epichem is debt free and one of the most advanced laboratories in Australasia with 18 PHD + staff. Revenue is steadily increasing..



12. The company has $3.2m cash and the ability to gain another $2.4 from Oppies before the end of November with no % to brokers, pure company money.

13 The company has stated we will have an update next month.

14 on the 28th PAA are to present at a Biotech Expo/conference.

15. The company have stated they have increased the Primary recruitment sites to 3 to act as a hub to enroll specific cases of K9s with Lymphoma B.



16, Ethics approval gained, 7000 pills in Australia.

17, MPL works very quickly, absorption is swift , bloods on day 4 of trial will demonstrate this,,, ( we await confirmation a positive effect) but as Phase II V 2.0 one would assume similar or greater effect on LT70 psk...

please feel free to add Facts to this page . NZT